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Summary The concentrations of the soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and
vascular cell adhesion molecule-1 (VCAM-1) were investigated in 48 patients with colorectal cancer before treatment, and their relation to
clinical, histological and routine laboratory parameters was examined. Data were collected on tumour stage at presentation, presence. and
sites of metastatic disease, tumour pathology and results of routine laboratory tests. Serum concentrations of ICAM-1 and VCAM-1 wiare
significantly elevated in the patients with colorectal cancer in comparison with a group of healthy subjects (P < 0.00001). Levels of circulating
ICAM-1 and VCAM-1 were increased both in patients with local and those with metastatic disease. Although elevated in some patients
soluble E-cadherin and E-selectin concentrations were not significantly elevated compared with the control group (P = 0.71 and P= 0.052
respectively). The levels of circulating ICAM-1 were significantly correlated with those of VCAM-1 and E-selectin. A correlation was also found
between the serum concentrations of E-selectin and ICAM-1 and alkaline phosphatase, total white cell count and platelet count. VCAM-1 was
positively correlated with age and negatively with degree of tumour differentiation and haemoglobin concentration. The biological implications
and possible clinical relevance of these findings are discussed.
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Cellular adhesion molecules play an important role in the process
ofmetastasis. Positive andnegative regulation ofcell adhesion will
influence the process as metastatic cells break away from the
primary tumour, travel in the circulation and then adhere to cellular
and extracellular matrix elements in particular secondary sites.
Several families of cell adhesion molecules have been identified
together with specific aberrations in malignant diseases (Zetter,
1993). The cadherins, Ca++-dependent homotypic cell-cell adhe-
sion molecules, are essential for establishing and maintaining
intercellular connections. Epithelial cadherin (E-cadherin) plays a
crucial role in maintaining the integrity ofepithelial tissues and has
been positively correlated with tumour differentiation and nega-
tively with infiltrative tumour growth and metastatic potential in a
range ofcancer types (Takeichi, 1993; Shino et al, 1995). Selectins
are transmembrane glycoproteins that mediate heterotypic cell-cell
contact through Ca+-dependent interactions with cell surface
carbohydrates. In addition to mediating leucocyte adhesion to acti-
vated vascular endothelium, endothelial selectin (E-selectin) has
been shown to be involved in the adhesion of cancer cells to the
vasculature. Stronger adhesion to the endothelium is mediated
through other classes of adhesion molecules, namely the integrins
and cytokine-inducible endothelial cell adhesion molecules of the
immunoglobulin supergene family, such as intercellular adhesion
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molecule-I (ICAM-1) and vascular cell adhesion molecule-1
(VCAM-1) (Zetter, 1993; Pignatelli and Vessey, 1994).
A number of clinicopathological studies have suggested that
several cell adhesion molecules may play a role in infiltrative
growth and metastases ofcolorectal cancer. Down-regulation ofE-
cadherin expression is associated with dedifferentiation, progres-
sion and metastasis of colorectal cancers (Dorudi et al, 1993).
Invasiveness of colorectal tumour cell lines was prevented by
transfection ofE-cadherin cDNA (Liu et al, 1993) and, conversely,
treatment with E-cadherin antibody made colorectal cancer cell
lines less differentiated (Pignatelli et al, 1992).
Increased expression of E-selectin, ICAM-1 and VCAM-l has
been found in small vessels around colon neoplasms (Nelson et al,
1994; Banner et al, 1995; Suzuki et al, 1995; Ye et al, 1995).
Endothelial cells adjacent to metastatic sites have been shown to
express E-selectin more extensively than those adjacent to the
primary site, supporting a role for E-selectin in the metastatic
process (Ye et al, 1995). Human colon cancer cells have carbo-
hydrate surface antigens (previously defined as cancer-associated
antigens), sialyl Lewisa (CA 19-9) and sialyl Lewisx, which act as
ligands for E-selectin (Bagshawe and Rustin, 1995). Experimental
laboratory studies have suggested that the efficiency ofE-selectin-
mediated binding of colonic cancer cells to activated endothelial
cells correlates with the metastatic potential of the cells (Sawada
et al, 1994; Izumi et al, 1995; Tozeren et al, 1995). This adhesive
event may be one ofthe critical factors forthe metastatic spread of
colon cancer cells. Many reports have described the correlation
between metastatic disease and the expression ofsialyl Lewisx and
sialyl Lewisacarbohydrates (Albelda, 1993; Nakamori et al, 1993).
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Table 1 Characteristics of the patients with colorectal cancer MATERIALS AND METHODS
Number
Median age (years) (range)
Female
Male
Dukes' stage
A
B
C
D
Tumour pathology
Differentiation
Well
Moderate
Poor
Missing
Ulceration
Absent
Mild
Moderate
Severe
Missing
Inflammation
Mild
Moderate
Severe
Missing
Concomitant diseases
Inflammatory bowel disease
Acute gastric ulcer
Diverticulitis
Post-operative septicaemia
Cardiovascular diseases
Other cancers
Diabetes
Osteoarthritis
Other
Survival (months) (range)
Censored (alive)
48
70 (40-89)
19
29
7
21
9
11
16
15
9
10
14
12
11
10
11
10
4
10
2
1
1
1
5
2
3
0-51
37
Patients
Forty-eight patients with colorectal cancer were studied at presen-
tation before treatment. The characteristics of the patients are
presented in Table 1. Venous blood samples for the measurement
of soluble adhesion molecules were taken on admission. At the
same time, full routine haematological and biochemical testing
was carried out, namely haemoglobin, total white cell count,
platelet count, albumin, creatinine, carcinoembryonic antigen
(CEA) and liver function tests: alkaline phosphatase (ALP),
aspartate-transaminase (AST) or alanine-transaminase (ALT) and
bilirubin. Tumour staging at presentation was according to Dukes'
classification of colorectal cancer (Turnbull, 1967). The tumour
pathology was independently reviewed by a single pathologist and
the primary tumours were graded for degree of differentiation,
presence and degree of ulceration and inflammation (for differen-
tiation: well, moderately or poorly differentiated cancer; for ulcer-
ation and inflammation: absent, slight, moderate, severe). The site
of metastasis was documented together with any concomitant
illness. Patients were followed prospectively with a follow-up
period from 20 to 51 months and dates and cause of death deter-
mined when applicable.
The control group consisted of 52 healthy volunteers (median
age 34 years, range 20-80 years, 28 women and 24 men). In the
case of E-cadherin, a subgroup of 30 of the samples was assayed
(median age 43 years, range 21-80 years, 17 women and 13 men).
Assay of soluble adhesion molecules
For assay of soluble adhesion molecules venous blood samples
were collected into plain tubes, allowed to clot and within 1 h of
collection were centrifuged at 800 g for 10 min. The serum was
removed, aliquoted and stored at -80°C until assayed.
Concentrations of soluble ICAM-1, VCAM-1, E-selectin and E-
cadherin were measured with commercially available sandwich
ELISA kits based on dual monoclonal antibodies (R & D Systems
Europe, Abingdon, UK, for ICAM-1, VCAM-1 and E-selectin;
Takara Shuzo, Otsu, Japan, for E-cadherin), according to the
manufacturers' protocols.
Recently, circulating forms of several adhesion molecules,
including E-cadherin, E-selectin, ICAM-1 and VCAM-1, have
been described with their concentrations being increased in
inflammatory and malignant diseases, e.g. malignant melanoma,
gastrointestinal cancer, lymphoma, hepatocellular cancer (Gearing
et al, 1992; Banks et al, 1993; Katayama et al, 1994; Jones et al,
1995; Wittig et al, 1996). Although little investigated so far,
soluble forms of adhesion molecules have been linked to clinical
behaviour of tumours. For example, circulating E-selectin levels
have been found to be significantly elevated in patients with
metastatic compared with patients with non-metastatic colorectal
cancer (Ye et al, 1995; Wittig et al, 1996).
In the present study, we investigated the concentrations of
soluble forms of cell adhesion molecules E-cadherin, E-selectin,
ICAM-1 and VCAM-1 in patients with colorectal cancer before
treatment and their relation to clinical, pathological and routine
laboratory parameters.
Statistical analysis
Data was analysed using the Statistical Package for Social
Sciences (SPSS). The data was not normally distributed and
accordingly was analysed using non-parametric tests. Comparison
of the level of soluble adhesion molecules in colorectal cancer
patients and healthy subjects was carried out using the
Mann-Whitney U-test. The difference was considered tobe signif-
icant when the two-sided P-value was less than 0.05. A correlation
matrix ofthe levels ofsoluble adhesion molecules and the clinical,
pathological and laboratory parameters was calculated using the
Spearman rank correlation method.
RESULTS
Concentrations of soluble E-cadherin, E-selectin, ICAM-1 and
VCAM-1 in the control and patient groups are shown in Figure 1
(A-D) and Table 2. Elevated soluble adhesion molecule levels were
defined as being greaterthan the 95th percentile ofhealthy subjects.
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Figure 1 (A-D) Serum concentration of soluble E-cadherin (A), E-selectin (B), ICAM-1 (C) and VCAM-1 (D) in normal healthy controls and patients with
colorectal cancer. The median values for each group are shown by horizontal bars and dotted lines represent the 95th percentile of the control group
Table 2 Serum concentrations of E-cadherin, E-selectin, ICAM-1 and
VCAM-1 in the control group of healthy subjects
Number of Median Minimum Maximum 95th
samples (ng ml-') (ng ml-) (ng ml-') Percentile
(ng ml-1)
E-cadherin 30 3.53 1.32 6.88 6.85
E-selectin 52 40.5 18.0 97.0 77.0
ICAM-1 52 245.5 168.0 430.0 395.8
VCAM-1 52 695.0 451.5 1124.2 1029.0
Table 3 Spearman rank correlation coefficients for levels of circulating
soluble adhesion molecules
E-cadherin E-selectin ICAM-1 VCAM-1
E-cadherin -
E-selectin 0.12 -
ICAM-1 0.15 0.41 ** -
VCAM-1 0.003 0.05 0.28* -
*P< 0.05, **P< 0.01.
Soluble ICAM-1 and VCAM-1 concentrations were found to be
significantly elevated in comparison with the healthy subjects
(median values 349.0 ng ml-', range 160.0-1347.0 ng ml-',
P<0.00001 and 986.Ong ml-', range 426.0-2291.Ong ml-',
P < 0.00001 respectively). The concentrations of soluble E-
cadherin and E-selectin were not significantly elevated in
colorectal cancer patients compared with the control group
(median values 3.17 ng ml-', range 1.37-13.04 ng ml', P = 0.71
and 51.0 ng ml', range 18.0-105.0 ng ml', P = 0.052 respec-
tively), although some patients had high concentrations of the
adhesion molecules and with E-selectin the difference between the
groups approached statistical significance.
When comparing separately the patients with local and
metastatic disease with the control group of healthy subjects, we
found significant elevation of concentrations of ICAM-1 and
VCAM-1 in both metastatic and non-metastatic colorectal cancer
but no increase in levels of soluble E-cadherin and E-selectin
regardless of the stage of disease (Figure 2A-D). There was no
significant difference between the median serum concentrations of
E-selectin, ICAM-1 and VCAM-1 of the patients with local
disease (Dukes' stages A and B) compared with the patients with
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Figure 2 (A-D) Serum concentration of soluble E-cadherin (A), E-selectin (B), ICAM-1 (C) and VCAM-1 (D) in normal healthy controls and patients with
colorectal cancer divided into local disease confined to bowel wall (Dukes' A and B) and advanced lymph nodal or metastatic disease (Dukes' C and D). The
median values for each group are shown by horizontal bars and dotted lines represent the 95th percentile of the control group
Table 4 Spearman rank correlation for concentrations of circulating soluble adhesion molecules and clinical,
laboratory and pathological parameters
E-cadherin E-selectin ICAM-1 VCAM-1
Age 0.17 -0.08 0.15 0.58***
Sex 0.06 0.32* 0.06 0.10
Stage 0.40* -0.08 0.18 -0.12
Differentiation 0.11 0.12 0.23 0.36*
Inflammation 0.28 0.02 0.10 0.19
Ulceration 0.11 0.15 0.22 0.15
CEA 0.18 0.10 0.10 0.10
ALT 0.20 0.006 0.11 0.02
ALP 0.05 0.42** 0.45** 0.06
Bilirubin -0.11 0.21 0.08 0.27
Serum albumin 0.15 -0.14 -0.006 0.20
Creatinine 0.21 -0.004 0.002 -0.03
Haemoglobin -0.06 -0.02 -0.19 -0.30*
White cell count 0.34* 0.49*** 0.37** 0.02
Platelet count 0.21 0.30* 0.41* -0.10
*P < 0.05, **P < 0.01, ***P < 0.001.
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disease metastatic to regional lymph nodes or liver (Dukes' stages
C and D). The patients with Dukes' stages C and D cancer had
higher serum concentrations of soluble E-cadherin in comparison
with the patients with Dukes' stages A and B but the difference
failed to reach statistical significance (P = 0.051).
The levels ofcirculating ICAM-1 were found to be significantly
correlated with the levels of circulating VCAM-1 and E-selectin
(Table 3).
To determine whether the concentration of soluble adhesion
molecules is influenced by tumour cell pathology, presence of
inflammation or impaired liver or renal function, the level of corre-
lation between concentrations of soluble adhesion molecules and
tumour pathology, stage, markers of liver function (bilirubin, ALP,
ALT, serum albumin), renal function (serum creatinine) and routine
haematological parameters (haemoglobin, total white cell count
and platelet count) was examined (Table 4). The serum concentra-
tion of VCAM-1 was significantly correlated with the degree of
tumour differentiation with higher serum levels detected in patients
with poorly differentiated tumours. No significant correlation was
found between the tumourpathology and levels ofthe other soluble
adhesion molecules. However, the analysis was biased by the
missing data on grading ofdifferentiation, inflammation and ulcer-
ation, with five of the cases being inoperable and five cases being
unavailable for independent histological review. When the serum
concentrations of adhesion molecules in the group with missing
pathology (halfofwhich by definition were more likely to be those
with more advanced and unresectable disease) were examined,
they were similar to the high-grade tumours, with a trend to be
higher than concentrations for low-grade tumours, but the differ-
ence did not reach statistical significance (data not shown).
A significant correlation was found between the serum concen-
trations of E-selectin and ICAM-1 and alkaline phosphatase, total
white cell count and platelet count. VCAM-1 was negatively
correlated withhaemoglobin concentration andpositively with age
(Table 4). However, no correlation between VCAM-1 and age was
observed in the healthy control group, although a slightly young
group overall (Spearman rank correlation coefficient = 0.09).
Soluble E-selectin concentrations were higher in men with
colorectal cancerthan in women (median value formen 61.0ngml-l,
range 18.0-105.0 ng ml-' and median value for women 45.0 ng ml-l,
range 20.0-81.0 ng ml-1, P = 0.026), but no association between
soluble E-selectin and gender was found in the control group.
As elevation of soluble adhesion molecules has been described
in a variety of inflammatory conditions, we collected information
on any concomitant illnesses of the colorectal cancer patients
(Table 1). Two patients had inflammatory bowel disease, one with
diverticulitis and one with an acute gastric ulcer. Elevated serum
concentrations ofICAM-1 were observed in all four ofthem, ofE-
selectin in three and ofVCAM-1 in one. One patient died immedi-
ately post-operatively from septicaemia. The soluble adhesion
molecule concentrations were normal in this case with the excep-
tion of VCAM-1, which was mildly elevated.
DISCUSSION
This study demonstrates that the serum concentrations ofICAM-1
and VCAM-1 are elevated in patients with colorectal cancerbefore
treatment. The soluble adhesion molecules were elevated both in
local and in metastatic disease and no correlation of their
concentrations with the stage of the disease was seen. Circulating
ICAM-1 has been reported to be increased in malignant
melanoma, Hodgkin's disease and gastrointestinal malignancies
and has been found to be associated with disease stage and
prognosis in melanoma, hepatocellular carcinoma and Hodgkin's
disease (Banks et al, 1993; Gruss et al, 1993; Kageshita et al, 1993;
Shimizu et al, 1995). Our results extend these observations for
patients with colorectal cancer and for the first time report elevated
serum concentrations of VCAM-1 in colorectal cancer. This
finding is in keeping with our previous observations of elevated
VCAM-1 in patients with different gastrointestinal cancers and
with gastric cancer, in particular, in which VCAM-1 concentra-
tions seems to have independent prognostic significance (Banks
et al, 1993; Velikova et al, 1997).
The source, the molecular nature and the biological significance
of the released soluble adhesion molecules is not yet known.
VCAM-1 is known to be expressed predominantly on activated
endothelial cells, dendritic cells and renal proximal tubule cells.
ICAM-1 is expressed on leucocytes, endothelial cells and antigen-
presenting cells. Both soluble adhesion molecules are up-regulated
by inflammatory cytokines, such as interleukin 1, tumour necrosis
factor alpha and interferon gamma (Zetter, 1993). Enzymatic
cleavage ofcell surface adhesion molecules or secretion ofalterna-
tively spliced forms lacking the transmembrane domain have been
suggested as possible mechanisms of their elevation in the sera
(Meager et al, 1996). Cytokine stimulation of cultured human
hepatocytes certainly induces cell surface expression of ICAM-1
and increases soluble ICAM-1 in the culture medium (Thomson et
al, 1994). ICAM-1 has been described on malignant epithelial
tissue, including metastatic gastric cancer cells, melanoma cell
lines and hepatocellular cancer cells (Natali et al, 1990; Koyama et
al, 1992; Torii et al, 1993) and may be the source of at least some
of the soluble ICAM-1 present in the sera of such cancer patients.
However, there are no data describing the expression of ICAM-1
or VCAM-1 on colon cancer cells. Increased expression of E-
selectin, ICAM-1 and VCAM-1 has been found in venules around
colon cancer primary and metastatic sites (Suzuki et al, 1995), and
conceivably these may be the producing sites of circulating
adhesion molecules in colon cancer.
After observations of a strong correlation of circulating ICAM-
1, VCAM-1, E-cadherin and E-selectin with serum alkaline phos-
phatase in patients with gastric cancer, we have suggested that
soluble adhesion molecules might have a biliary route ofexcretion
and their clearance might be impaired in the presence of intra-
hepatic cholestasis secondary to liver metastases (Velikova et al,
1997). In the colorectal cancer patients, the correlation between
some soluble adhesion molecules and serum alkaline phosphatase
is still present but not as strongly as in the gastric cancer patients.
This could be due to the higher proportion of patients with
advanced and metastatic disease in the group of patients with
gastric cancer.
We found that the serum concentrations of ICAM-1 and E-
selectin correlated with the total white cell count, suggesting the
possibility of release of activating inflammatory cytokines by the
white cells up-regulating the release ofsoluble adhesion molecules
from endothelial cells (Carlos and Harlan, 1994; McEver, 1994).
Of 13 patients with elevated soluble ICAM-1, only three patients
had a white cell count above 10 x 109 1-1, whereas of the four
patients with total white cell count above 10 x 109 1-', soluble
ICAM-1 concentrations were outside the normal range in three
patients and almost abnormal in the fourth one. This observation
British Journal ofCancer (1998) 77(11), 1857-1863 0CancerResearch Campaign 19981862 G Velikova etal
(although based on small numbers) is in keeping with the report of
elevated serum ICAM-1 in inflammatory diseases and suggests
that release of inflammatory cytokines from white cells is one
possible mechanism ofelevation ofICAM-1 in patients with colon
cancer. It may also suggest a possible role ofthe soluble adhesion
molecules in the inflammatory response of the host. The descrip-
tive information from our study showing an increase in soluble
ICAM-1 in all four patients with known inflammatory diseases of
the gastrointestinal system emphasizes the probable multifactorial
mechanisms of elevation of soluble adhesion molecules and
underlines the importance ofconsidering concurrent inflammatory
conditions when interpreting measurements of soluble adhesion
molecules.
The association of E-selectin and ICAM-1 with the platelet
count is interesting in the light ofthe reported possible endothelial
cell activation factor(s) released from activated platelets.
Hakomori et al (1994) have suggested that tumour cells can not
activate endothelial cells directly but can activate native platelets,
which in turn activate endothelial cells to express E-selectin,
leading to tumour cell adhesion.
We further observed a positive correlation between serum
concentrations of VCAM-1 and the age of the patients. No such
correlation was found in the control group ofhealthy subjects, but
we should note that the median age was significantly lower than
that of the colorectal cancer patients. Therefore, the possibility of
age effect on the serum levels of VCAM-1 can not be excluded,
and future studies should take this possible effect into account.
Most studies of soluble adhesion molecules in gastrointestinal
malignancies have concentrated on measurements of E-cadherin
and E-selectin. Reduced expression of E-cadherin on colon and
gastric cancer cells have been associated with dedifferentiation
and distant metastasis (Dorudi et al, 1993; Mayer et al, 1993;
Shino et al, 1995). Katayama et al (1994) have found significantly
increased concentrations ofcirculating E-cadherin in patients with
gastric cancer before surgery. Our study did not confirm these
observations in colorectal cancer patients. We did not show any
significant increase in serum concentration of E-cadherin or any
correlation of soluble E-cadherin levels with degree of tumour
differentiation.
E-selectin has been implicated in the adhesion of colorectal
cancer cells expressing sialyl Lewisx and sialyl Lewisa to activated
endothelial cells (Sawada et al, 1994; Izumi et al, 1995; Tozeren et
al, 1995). Recent observations have shown that soluble E-selectin
and VCAM-1 promote angiogenesis in rat cornea (Koch et al,
1995). Increased serum concentrations of E-selectin have been
found in patients with metastatic colorectal cancer but not in
patients with non-metastatic disease (Wittig et al, 1996). As the
authors have not observed correlation of soluble E-selectin
concentrations and markers of inflammation (serum level of C-
reactive protein, fibrinogen and tumour necrosis factor alpha),
they have proposed that increased soluble E-selectin might reflect
neovascularization at the sites of the metastases, linking together
the processes of cell adhesion and angiogenesis. We could not
confirm the above finding, although in our study a few patients
with colorectal cancer had serum concentrations of E-selectin
above the normal range, and the difference from the normal group
was approaching statistical significance. Possible explanations for
the different results in similar groups of patients include: (1)
different assays measuring different soluble fragments of E-
selectin molecule; (2) relatively small proportion of patients with
metastatic disease (11 out of 48) in our patient group and a rela-
tively high proportion of patients with localized colon cancer (28
out of48). However, these results should encourage further studies
looking at serum concentrations of E-selectin in large groups of
colorectal cancer patients together with measurement ofits known
ligand sialyl Lewisa (CA 19-9), which is a tumour marker test now
available for routine clinical practice.
Our study has shown marked elevation of soluble adhesion
molecules ICAM-l and VCAM-1 in patients with different stages
of colorectal cancer. Other clinicopathological studies have
reported an increase in the serum concentrations ofseveral soluble
adhesion molecules, i.e. ICAM-1, E-selectin and more recently
VCAM-1, in cancerpatients with arange ofmalignancies andhave
shown associations with the tumourdifferentiation, stage andprog-
nosis. A number of in vitro laboratory studies have suggested that
adhesion molecules may play a role in the processes ofadhesion of
tumour cells to endothelium, neovascularization at the metastatic
sites and host inflammatory response to cancer. It will be necessary
to determine the biological implications and the clinical signifi-
cance ofthe many soluble adhesion molecules in cancer.
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